Genprex's IPO

Genprex raised a round of funding on March 29, 2018. Investors include Public.

Genprex is a privately held, clinical-stage biopharmaceutical company developing nanovesicle therapies that control universal cancer pathways to unlock the unrealized potential of a variety of targete…

Articles about Genprex's IPO: